In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events.
Where this comes from
- Record sourced from PubMed, PMID 33819059.
- Also identified by DOI 10.7326/ACPJ202104200-043.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Guimarães HP, Lopes RD, de Barros E Silva PG, et al. <b>Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve.</b> N Engl J Med. 2020;383:2117-26. 33196155.
Medical subject headings
- Atrial Fibrillation
- Warfarin